Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs TideMedix

Mevo Health
Graded #326

Higher grade

vs+5.900000000000006
TideMedix
Graded #457

Lower grade

The verdict

Mevo Health takes it — 60.2/100 to 54.3/100.

Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +11
56
45
Dose & formulationMevo Health +43
83
40
Clinical oversightTideMedix +7
67
74
Labs & monitoringEven
52
52
FulfillmentTideMedix +6
57
63
Contract termsTideMedix +41
20
61
Mevo Health · left barTideMedix · right bar

The numbers

MetricMevo HealthTideMedix
WeighScore60.2/10054.3/100
GradeCC
Scorecard rank#326#457
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$259/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
TideMedix

Graded #457 · C

Strengths

  • Offers both semaglutide and tirzepatide GLP-1 weight care
  • Treatment only after licensed-provider review when clinically appropriate
  • Fully online assessment — no in-person visit required
  • Published patient-care phone line: (833) 365-5589

Where it loses points

  • Pricing not published on the site — shown only during intake
  • Prescribing medical group and pharmacy partner not named publicly
  • LegitScript certification claimed via a self-hosted badge; not independently verifiable
  • Medication form (compounded vs brand) not stated on the site
  • Once shipped, all sales are final — no refunds on prescriptions

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard